Table 3.

Antibody titers during vaccinations of CHP-NY-ESO-1/poly-ICLC

Lab-ID	Patient No	Poly-ICLC dose	Baseline	1 cycle	2 cycles	3 cycles	4 cycles	5 cycles	6 cycles
Lab-1572	1	0.5 mg	–	–	–	× 6400	× 25,600	× 25,600	× 25,600
Lab-1567	2	0.5 mg	–	–	–	–	–	× 400	× 400
Lab-1393	3	0.5 mg	–	–	× 6400	× 25,600	× 25,600	× 25,600	× 25,600
Lab-1434	4	0.5 mg	–	× 6400	× 25,600	× 102,400	× 102,400	× 102,400	× 102,400
Lab-2154	5	0.5 mg	–	–	–	–	–	× 25,600	× 25,600
Lab-2155	6	0.5 mg	× 6400	× 6400	× 25,600	× 25,600	× 25,600	× 25,600	× 25,600
Lab-2156	7	1.0 mg	–	–	–	× 6400	× 6400	× 25,600	NA
Lab-2159	10	1.0 mg	–	× 400	× 400	× 6400	× 25,600	× 25,600	× 25,600
Lab-2160	11	1.0 mg	–	× 400	× 1600	× 6400	× 6400	× 6400	× 6400
Lab-2161	12	1.0 mg	–	–	–	–	× 400	× 1600	× 1600
Lab-2006	14	1.0 mg	–	–	× 400	× 1600	× 6400	× 6400	× 25,600
Lab-2296	16	1.0 mg	–	–	–	× 400	× 400	× 1600	NA